Annual CAPEX
N/A
December 31, 2023
Summary
- AVDL annual capital expenditures is not available.
Performance
AVDL CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2024
Summary
- AVDL quarterly capital expenditures is not available.
Performance
AVDL Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2024
Summary
- AVDL TTM capital expenditures is not available.
Performance
AVDL TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
AVDL CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
AVDL CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Avadel Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $716.00 K(+2653.8%) | $0.00(-100.0%) | $716.00 K(0.0%) |
| Sep 2022 | - | $716.00 K(>+9900.0%) | $716.00 K(+2653.8%) |
| Dec 2021 | $26.00 K(-73.5%) | $0.00(0.0%) | $26.00 K(-71.4%) |
| Sep 2021 | - | $0.00(0.0%) | $91.00 K(-26.6%) |
| Jun 2021 | - | $0.00(-100.0%) | $124.00 K(0.0%) |
| Mar 2021 | - | $26.00 K(-60.0%) | $124.00 K(+26.5%) |
| Dec 2020 | $98.00 K(+237.9%) | $65.00 K(+97.0%) | $98.00 K(+197.0%) |
| Sep 2020 | - | $33.00 K(>+9900.0%) | $33.00 K(+13.8%) |
| Dec 2019 | $29.00 K(-99.9%) | $0.00(0.0%) | $29.00 K(-27.5%) |
| Sep 2019 | - | $0.00(-100.0%) | $40.00 K(-63.0%) |
| Jun 2019 | - | -$1000.00(-103.3%) | $108.00 K(-99.5%) |
| Mar 2019 | - | $30.00 K(+172.7%) | $20.17 M(-0.1%) |
| Dec 2018 | $20.18 M(-62.4%) | $11.00 K(-83.8%) | $20.18 M(-4.8%) |
| Sep 2018 | - | $68.00 K(-99.7%) | $21.20 M(-71.2%) |
| Jun 2018 | - | $20.06 M(>+9900.0%) | $73.48 M(+37.6%) |
| Mar 2018 | - | $41.00 K(-96.0%) | $53.41 M(-0.5%) |
| Dec 2017 | $53.70 M(+4371.4%) | $1.03 M(-98.0%) | $53.70 M(+1.6%) |
| Sep 2017 | - | $52.35 M(<-9900.0%) | $52.87 M(+6838.7%) |
| Jun 2017 | - | -$13.00 K(-103.9%) | $762.00 K(-29.1%) |
| Mar 2017 | - | $334.00 K(+66.2%) | $1.07 M(-10.5%) |
| Dec 2016 | $1.20 M(-26.3%) | $201.00 K(-16.3%) | $1.20 M(-22.6%) |
| Sep 2016 | - | $240.00 K(-20.0%) | $1.55 M(-10.3%) |
| Jun 2016 | - | $300.00 K(-34.8%) | $1.73 M(-6.7%) |
| Mar 2016 | - | $460.00 K(-16.7%) | $1.85 M(+13.9%) |
| Dec 2015 | $1.63 M(-5.7%) | $552.00 K(+32.1%) | $1.63 M(+16.3%) |
| Sep 2015 | - | $418.00 K(-1.6%) | $1.40 M(-16.4%) |
| Jun 2015 | - | $425.00 K(+81.6%) | $1.68 M(+7.2%) |
| Mar 2015 | - | $234.00 K(-27.8%) | $1.56 M(-9.5%) |
| Dec 2014 | $1.73 M(+67.9%) | $324.00 K(-53.2%) | $1.73 M(+3.7%) |
| Sep 2014 | - | $692.00 K(+121.1%) | $1.67 M(+36.0%) |
| Jun 2014 | - | $313.00 K(-21.6%) | $1.23 M(+21.9%) |
| Mar 2014 | - | $399.00 K(+51.7%) | $1.01 M(-2.2%) |
| Dec 2013 | $1.03 M(-3.7%) | $263.00 K(+4.8%) | $1.03 M(-0.1%) |
| Sep 2013 | - | $251.00 K(+169.9%) | $1.03 M(-3.7%) |
| Jun 2013 | - | $93.00 K(-78.0%) | $1.07 M(-7.4%) |
| Mar 2013 | - | $422.00 K(+59.8%) | $1.16 M(+8.0%) |
| Dec 2012 | $1.07 M(-43.8%) | $264.00 K(-9.3%) | $1.07 M(-4.9%) |
| Sep 2012 | - | $291.00 K(+63.5%) | $1.12 M(-1.0%) |
| Jun 2012 | - | $178.00 K(-47.0%) | $1.14 M(-15.2%) |
| Mar 2012 | - | $336.00 K(+5.3%) | $1.34 M(-29.7%) |
| Dec 2011 | $1.90 M | $319.00 K(+5.6%) | $1.90 M(-1.4%) |
| Sep 2011 | - | $302.00 K(-20.7%) | $1.93 M(-30.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | - | $381.00 K(-57.7%) | $2.77 M(-26.4%) |
| Mar 2011 | - | $901.00 K(+160.4%) | $3.76 M(+4.6%) |
| Dec 2010 | $3.60 M(+103.3%) | $346.00 K(-69.7%) | $3.60 M(+3.1%) |
| Sep 2010 | - | $1.14 M(-16.8%) | $3.49 M(+20.2%) |
| Jun 2010 | - | $1.37 M(+86.7%) | $2.90 M(+38.7%) |
| Mar 2010 | - | $736.00 K(+209.2%) | $2.10 M(+18.4%) |
| Dec 2009 | $1.77 M(-49.8%) | $238.00 K(-57.3%) | $1.77 M(+9.3%) |
| Sep 2009 | - | $557.00 K(-1.2%) | $1.62 M(-43.7%) |
| Jun 2009 | - | $564.00 K(+37.2%) | $2.88 M(+4.7%) |
| Mar 2009 | - | $411.00 K(+372.4%) | $2.75 M(-22.1%) |
| Dec 2008 | $3.52 M(-68.7%) | $87.00 K(-95.2%) | $3.52 M(+0.4%) |
| Sep 2008 | - | $1.81 M(+316.8%) | $3.51 M(-47.7%) |
| Jun 2008 | - | $435.00 K(-63.4%) | $6.71 M(-27.6%) |
| Mar 2008 | - | $1.19 M(+1505.4%) | $9.26 M(-17.8%) |
| Dec 2007 | $11.27 M(+76.3%) | $74.00 K(-98.5%) | $11.27 M(-27.0%) |
| Sep 2007 | - | $5.01 M(+67.7%) | $15.45 M(+44.2%) |
| Jun 2007 | - | $2.99 M(-6.6%) | $10.71 M(+20.2%) |
| Mar 2007 | - | $3.20 M(-24.8%) | $8.92 M(+39.4%) |
| Dec 2006 | $6.39 M(-43.5%) | $4.25 M(+1446.5%) | $6.39 M(+10.9%) |
| Sep 2006 | - | $275.00 K(-76.9%) | $5.77 M(-21.6%) |
| Jun 2006 | - | $1.19 M(+76.0%) | $7.36 M(-35.6%) |
| Mar 2006 | - | $676.00 K(-81.4%) | $11.43 M(+0.9%) |
| Dec 2005 | $11.33 M(-18.1%) | $3.63 M(+94.5%) | $11.33 M(+27.1%) |
| Sep 2005 | - | $1.86 M(-64.6%) | $8.91 M(-25.8%) |
| Jun 2005 | - | $5.26 M(+823.5%) | $12.02 M(+15.9%) |
| Mar 2005 | - | $570.00 K(-53.0%) | $10.37 M(-25.0%) |
| Dec 2004 | $13.84 M(+387.0%) | $1.21 M(-75.6%) | $13.84 M(-8.3%) |
| Sep 2004 | - | $4.97 M(+37.4%) | $15.10 M(+49.1%) |
| Jun 2004 | - | $3.62 M(-10.4%) | $10.13 M(+54.4%) |
| Mar 2004 | - | $4.04 M(+63.2%) | $6.56 M(+130.8%) |
| Dec 2003 | $2.84 M(+98.0%) | $2.47 M(>+9900.0%) | $2.84 M(+672.0%) |
| Sep 2003 | - | $0.00(-100.0%) | $368.00 K(0.0%) |
| Jun 2003 | - | $49.00 K(-84.6%) | $368.00 K(+15.4%) |
| Mar 2003 | - | $319.00 K(-36.2%) | $319.00 K(-36.2%) |
| Dec 2002 | $1.44 M(+21.8%) | - | - |
| Dec 2001 | $1.18 M(+59.8%) | - | - |
| Dec 2000 | $737.00 K(+9.5%) | - | - |
| Dec 1999 | $673.00 K(-40.5%) | - | - |
| Dec 1998 | $1.13 M(-29.3%) | - | - |
| Mar 1998 | - | $500.00 K(+150.0%) | $500.00 K(+150.0%) |
| Dec 1997 | $1.60 M(+6.7%) | - | - |
| Dec 1996 | $1.50 M | - | - |
| Mar 1996 | - | $200.00 K | $200.00 K |
FAQ
- What is the all time high annual CAPEX for Avadel Pharmaceuticals?
- What is the all time high quarterly CAPEX for Avadel Pharmaceuticals?
- What is the all time high TTM CAPEX for Avadel Pharmaceuticals?
What is the all time high annual CAPEX for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual capital expenditures is $53.70 M
What is the all time high quarterly CAPEX for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly capital expenditures is $52.35 M
What is the all time high TTM CAPEX for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high TTM capital expenditures is $73.48 M